文献速递传染病防控与疫情报告卫生政策与健康促进

拉沙热暴发、数学模型与疾病参数:系统综述与Meta分析

Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis.
PubMed 文献 · Lancet Glob Health · 2024-01-01

该研究系统检索截至2024年6月13日的文献,纳入193篇出版物、提取440个参数估计,分析拉沙热暴发规模、传播模型与流行病学参数。估计合并总随机效应病死率为33.5%(95%CI 25.8-42.2,I²=95%),症状发作至入院延迟均值为8.19天(95%CI 7.31-9.06,I²=93%),并指出拉沙热参数估计缺乏以及监测覆盖不足。

要点

  • 合并总随机效应病死率为33.5%(95%CI 25.8-42.2,I²=95%)。
  • 合并总随机效应症状发作至入院延迟均值为8.19天(95%CI 7.31-9.06,I²=93%)。
  • 普通人群血清阳性率估计范围为2.6%(6/232)至58.2%(103/177),覆盖率差。

核心结论

  • 研究强调尽管拉沙热在西非疾病负担高,但缺乏经验性参数估计。
  • 需要改进监测方法以捕获人类轻症病例并进一步覆盖啮齿动物种群,以更好理解拉沙热传播动力学。
  • 解决这些差距对于开发准确的数学模型和为循证干预提供信息至关重要。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed和Web of Science从数据库建库至2024年6月13日的同行评审研究。
  • 纳入报告拉沙热暴发规模、传播模型、病毒进化、传播、自然史、严重程度、血清阳性率或危险因素的英文同行评审原创研究文章。
  • 最终纳入193篇出版物,提供440个相关参数估计;研究注册于PROSPERO(注册号CRD42023393345)。

主要发现

  • 普通人群血清阳性率估计范围为2.6%(6/232)至58.2%(103/177),时空覆盖差。
  • 仅获得四个基本再生数估计,范围为1.13至1.40。
  • 合并总随机效应病死率为33.5%(95%CI 25.8-42.2,I²=95%),严重程度可能因与特定拉沙病毒谱系相关的地理区域而异。
  • 合并总随机效应症状发作至入院延迟均值为8.19天(95%CI 7.31-9.06,I²=93%),其他流行病学延迟在现有文献中表征不足。

关键数值与推荐

  • 合并总随机效应病死率为33.5%(95%CI 25.8-42.2,I²=95%)。
  • 合并总随机效应症状发作至入院延迟均值为8.19天(95%CI 7.31-9.06,I²=93%)。
  • 普通人群血清阳性率估计范围为2.6%(6/232)至58.2%(103/177)。
  • 基本再生数估计范围为1.13至1.40,仅四个估计可用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 普通人群血清阳性率估计的时空覆盖差,突显拉沙热风险的空间不确定性。
  • 仅四个基本再生数估计可用。
  • 其他流行病学延迟在现有文献中表征不足。
  • 尽管拉沙热在西非疾病负担高,但缺乏经验性参数估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the epidemiological parameters and transmission dynamics of Lassa fever, a significant public health threat in west Africa caused by the rodent-borne Lassa virus, is crucial for informing evidence-based interventions and outbreak response strategies. Therefore, our study aimed to collate and enhance understanding of the key epidemiological parameters of Lassa fever. METHODS: We conducted a systematic review, searching PubMed and Web of Science for peer-reviewed studies published from database inception up to June 13, 2024, to compile and analyse key epidemiological parameters, mathematical models, and outbreaks of Lassa fever. English-language, peer-reviewed, original research articles were included if they reported on Lassa fever outbreak sizes, transmission models, viral evolution, transmission, natural history, severity, seroprevalence, or risk factors. Non-peer-reviewed literature was excluded. Data were extracted by two independent individuals from published literature, focusing on seroprevalence, transmissibility, epidemiological delays, and disease severity. We performed a meta-analysis to calculate pooled estimates of case-fatality ratios (CFRs) and the delay from symptom onset to hospital admission. This study is registered with PROSPERO (identifier number CRD42023393345). FINDINGS: The database search returned 5614 potentially relevant studies, and a further 16 studies were identified from backward citation chaining. After de-duplication and exclusion, 193 publications met our inclusion criteria and provided 440 relevant parameter estimates in total. Although Lassa virus is endemic in west Africa, the spatiotemporal coverage of general-population seroprevalence estimates (ranging from 2·6% [6/232] to 58·2% [103/177]) was poor, highlighting the spatial uncertainty in Lassa fever risk. Similarly, only four basic reproduction number estimates (ranging from 1·13 to 1·40) were available. We estimated a pooled total random effect CFR of 33·5% (95% CI 25·8-42·2, I2=95%) and found potential variation in severity by geographical regions typically associated with specific Lassa virus lineages. We estimated a pooled total random effect mean symptom-onset-to-hospital-admission delay of 8·19 days (95% CI 7·31-9·06, I2=93%), but other epidemiological delays were poorly characterised in the existing literature. INTERPRETATION: Our findings highlight the absence of empirical Lassa fever parameter estimates despite its high burden in west Africa. Improved surveillance approaches to capture mild cases in humans and to further cover rodent populations are needed to better understand Lassa fever transmission dynamics. Addressing these gaps is essential for developing accurate mathematical models and informing evidence-based interventions to mitigate the effect of Lassa fever on public health in endemic regions. FUNDING: UK Medical Research Council, National Institute for Health and Care Research, Academy of Medical Sciences, Wellcome, UK Department for Business, Energy, and Industrial Strategy, British Heart Foundation, Diabetes UK, Schmidt Foundation, Community Jameel, Royal Society, and Imperial College London. TRANSLATION: For the French translation of the abstract see Supplementary Materials section.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Doohan P, Jorgensen D, Naidoo TM, et al. Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis. Lancet Glob Health. 2024. PMID: 39577970. doi:10.1016/S2214-109X(24)00379-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。